PharmAthene Prices $15 Million Public Offering at $.50 per Share

PharmAthene, Inc. (PIP) today announced that it has priced a registered public offering of 4,300,000 shares of its common stock at a price to the public of $3.50 per share. The Company expects that the offering will yield net proceeds, before expenses, of approximately $14.1 million and intends to use the net proceeds of the offering for repayment of debt and general corporate purposes.